Cargando…

Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells

BACKGROUND AND OBJECTIVES: Cancer stem cells (CSCs) with tumorigenic potential are reported as the crucial factors of hepatocellular carcinoma (HCC) recurrence and therapy resistance. Bone mesenchymal stem cells (BMSCs) are documented to play an important role in the protection of hepatocytes. Bie J...

Descripción completa

Detalles Bibliográficos
Autores principales: Jingjing, Huang, Hongna, Huang, Wenfu, Zhang, Jianlin, Lv, Guochu, Huang, Yuanjia, Lin, Songlin, Chen, Yueqiang, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429943/
https://www.ncbi.nlm.nih.gov/pubmed/33632990
http://dx.doi.org/10.15283/ijsc20157
_version_ 1783750641196204032
author Jingjing, Huang
Hongna, Huang
Wenfu, Zhang
Jianlin, Lv
Guochu, Huang
Yuanjia, Lin
Songlin, Chen
Yueqiang, Hu
author_facet Jingjing, Huang
Hongna, Huang
Wenfu, Zhang
Jianlin, Lv
Guochu, Huang
Yuanjia, Lin
Songlin, Chen
Yueqiang, Hu
author_sort Jingjing, Huang
collection PubMed
description BACKGROUND AND OBJECTIVES: Cancer stem cells (CSCs) with tumorigenic potential are reported as the crucial factors of hepatocellular carcinoma (HCC) recurrence and therapy resistance. Bone mesenchymal stem cells (BMSCs) are documented to play an important role in the protection of hepatocytes. Bie Jia Jian pill (BJJP), a Traditional Chinese Medicine, has been used to treat liver fibrosis and liver cancer. This study aimed to explore the potential role of combined use of BJJP with BMSCs in HCC cell lines. METHODS AND RESULTS: Flow cytometry was used to identify BMSCs isolated from BALB/c mice and CSCs enriched from Huh7 cells by measuring CD24, CD133, CD44, CD73, CD105, CD166, CD29, CD14 and CD34. Differentiation potential of BMSCs was also determined. Cell viability and proliferation ability of CSCs were determined by CCK-8 assay and clone formation assay. The expressions of CSCs biomarkers and Wnt/β-catenin signal pathway related proteins were determined by PCR and western blot. TOP-Flash/FOP-Flash luciferase assay was applied to measure the activity of β-catenin/TCF. Compared with untreated CSCs, BJJP or BMSCs treatment alone on CSCs lead to increased miR-140 expression and cell apoptosis, as well as decreased expressions of CD24, CD133, EpCAM and cell viability. Downregualted expressions of Wnt/β-catenin signal pathway related proteins, Wnt3a and β-catenin were found in response to BJJP or BMSCs treatment alone. The combination of BJJP+BMSCs treatment on CSCs could further enhance the suppressive effect on CSCs. Down-regulation of miR-140 in CSCs partially blocked the effects of BMSCs or BMSCs+BJJP on the expressions of Wnt3a and β-catenin as well as the cell viability and apoptosis of CSCs. Reversed expression pattern was found in CSCs transfected with miR-140 overexpression. CONCLUSIONS: Taken together, we demonstrate that BJJP+BMSCs together could further enhance the suppressive effect on CSCs through regulating miR-140 and suppressing Wnt/β-catenin signal pathway. This study demonstrated the potential of BJJP+BMSCs in therapeutic treatment of HCC.
format Online
Article
Text
id pubmed-8429943
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Stem Cell Research
record_format MEDLINE/PubMed
spelling pubmed-84299432021-09-20 Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells Jingjing, Huang Hongna, Huang Wenfu, Zhang Jianlin, Lv Guochu, Huang Yuanjia, Lin Songlin, Chen Yueqiang, Hu Int J Stem Cells Original Article BACKGROUND AND OBJECTIVES: Cancer stem cells (CSCs) with tumorigenic potential are reported as the crucial factors of hepatocellular carcinoma (HCC) recurrence and therapy resistance. Bone mesenchymal stem cells (BMSCs) are documented to play an important role in the protection of hepatocytes. Bie Jia Jian pill (BJJP), a Traditional Chinese Medicine, has been used to treat liver fibrosis and liver cancer. This study aimed to explore the potential role of combined use of BJJP with BMSCs in HCC cell lines. METHODS AND RESULTS: Flow cytometry was used to identify BMSCs isolated from BALB/c mice and CSCs enriched from Huh7 cells by measuring CD24, CD133, CD44, CD73, CD105, CD166, CD29, CD14 and CD34. Differentiation potential of BMSCs was also determined. Cell viability and proliferation ability of CSCs were determined by CCK-8 assay and clone formation assay. The expressions of CSCs biomarkers and Wnt/β-catenin signal pathway related proteins were determined by PCR and western blot. TOP-Flash/FOP-Flash luciferase assay was applied to measure the activity of β-catenin/TCF. Compared with untreated CSCs, BJJP or BMSCs treatment alone on CSCs lead to increased miR-140 expression and cell apoptosis, as well as decreased expressions of CD24, CD133, EpCAM and cell viability. Downregualted expressions of Wnt/β-catenin signal pathway related proteins, Wnt3a and β-catenin were found in response to BJJP or BMSCs treatment alone. The combination of BJJP+BMSCs treatment on CSCs could further enhance the suppressive effect on CSCs. Down-regulation of miR-140 in CSCs partially blocked the effects of BMSCs or BMSCs+BJJP on the expressions of Wnt3a and β-catenin as well as the cell viability and apoptosis of CSCs. Reversed expression pattern was found in CSCs transfected with miR-140 overexpression. CONCLUSIONS: Taken together, we demonstrate that BJJP+BMSCs together could further enhance the suppressive effect on CSCs through regulating miR-140 and suppressing Wnt/β-catenin signal pathway. This study demonstrated the potential of BJJP+BMSCs in therapeutic treatment of HCC. Korean Society for Stem Cell Research 2021-02-28 /pmc/articles/PMC8429943/ /pubmed/33632990 http://dx.doi.org/10.15283/ijsc20157 Text en Copyright © 2021 by the Korean Society for Stem Cell Research https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jingjing, Huang
Hongna, Huang
Wenfu, Zhang
Jianlin, Lv
Guochu, Huang
Yuanjia, Lin
Songlin, Chen
Yueqiang, Hu
Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title_full Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title_fullStr Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title_full_unstemmed Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title_short Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells
title_sort bie jia jian pill combined with bone mesenchymal stem cells regulates microrna-140 to suppress hepatocellular carcinoma stem cells
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429943/
https://www.ncbi.nlm.nih.gov/pubmed/33632990
http://dx.doi.org/10.15283/ijsc20157
work_keys_str_mv AT jingjinghuang biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT hongnahuang biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT wenfuzhang biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT jianlinlv biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT guochuhuang biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT yuanjialin biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT songlinchen biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells
AT yueqianghu biejiajianpillcombinedwithbonemesenchymalstemcellsregulatesmicrorna140tosuppresshepatocellularcarcinomastemcells